Keyphrases
Stem Cells
100%
Advanced Breast Cancer
100%
Expression Profile
100%
Neoadjuvant Therapy
100%
Cell Signaling Pathways
100%
Pathway Genes
100%
Aldehyde Dehydrogenase 2 (ALDH2)
80%
Histone Deacetylase 2 (HDAC2)
60%
Cdc42
60%
Clinical Characteristics
40%
Breast Cancer Stem Cells
40%
Breast Cancer
20%
CTNNB1
20%
Gene Expression
20%
Clinical Patients
20%
Poor Prognosis
20%
Chemotherapy
20%
Survival Rate
20%
Cancer Tissue
20%
Paired T-test
20%
Overexpression
20%
RNA Expression
20%
Illumina
20%
Next-generation Sequencing
20%
Patient Survival
20%
Insulin-like Growth factor-1
20%
Neoadjuvant Chemotherapy
20%
Therapy Resistance
20%
Poor Survival
20%
Tumor Resection
20%
Local Advanced Breast Cancer
20%
Non-survival
20%
CCNE1
20%
PSENEN
20%
MiSeq Illumina
20%
Cell Panel
20%
Cyclin D2 (CCND2)
20%
TruSeq
20%
Downregulated Genes
20%
Upregulated Genes
20%
Stem Cell Genes
20%
FZD7
20%
Chemokine Ligand 12 (CXCL12)
20%
Presenilin
20%
Medicine and Dentistry
Breast Cancer
100%
Neoadjuvant Therapy
100%
Stem Cell
100%
ALDH1A1
50%
Histone Deacetylase 2
50%
Cancer Stem Cell
33%
Survival Rate
16%
Gene Expression
16%
Student T Test
16%
Cancer Tissue
16%
Therapy Resistance
16%
Neoadjuvant Chemotherapy
16%
Illumina MiSeq
16%
Next Generation Sequencing
16%
Cancer Surgery
16%
Insulin-Like Growth Factor 1
16%
Illumina Dye Sequencing
16%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
ALDH1A1
60%
Histone Deacetylase 2
60%
CDC42
60%
Cancer Stem Cell
40%
RNA
20%
Gene Expression
20%
Survival Rate
20%
Next Generation Sequencing
20%
Insulin-Like Growth Factor 1
20%
ALDH2
20%
Illumina MiSeq
20%
Illumina Dye Sequencing
20%
PSEN1
20%
Immunology and Microbiology
Stem Cell
100%
Cancer Stem Cell
40%
Gene Expression
20%
Survival Rate
20%
Cancer Tissue
20%
Next Generation Sequencing
20%
Illumina MiSeq
20%
Insulin-Like Growth Factor 1
20%
Illumina Dye Sequencing
20%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Histone Deacetylase 2
50%
Chemotherapy
33%
Malignant Neoplasm
16%
Neoplasm
16%
Survival Rate
16%
Therapy Resistance
16%
Insulin-Like Growth Factor 1
16%